| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/13/2004 | CA2499132A1 Solid and semi-solid polymeric ionic conjugates |
| 05/13/2004 | CA2486104A1 Tri-block polymers for nanosphere-based drug or gene delivery |
| 05/12/2004 | EP1418228A1 Macroencapsulated secretory cells |
| 05/12/2004 | EP1417974A1 Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy |
| 05/12/2004 | EP1417972A1 Stabilized teriparatide solutions |
| 05/12/2004 | EP1417970A2 Anti-allergic, anti-bacteric and anti-redden compound for eyes |
| 05/12/2004 | EP1417960A1 Sustained release micropellets and process for producing the same |
| 05/12/2004 | EP1417487A2 Epitope testing using hla |
| 05/12/2004 | EP1417239A1 Regioselectively reticulated polysaccharides |
| 05/12/2004 | EP1417236A2 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 05/12/2004 | EP1417232A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/12/2004 | EP1417229A2 Methods and compounds for the targeting of protein to exosomes |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417222A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralzing annti-p17 antibodies which specifically recognize said neutralizing epitope |
| 05/12/2004 | EP1417153A1 N,n-dinitramide salts as solubilizing agents for biologically active agents |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416990A1 Inhalation device with a pharmaceutical composition |
| 05/12/2004 | EP1416986A2 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 05/12/2004 | EP1416974A1 Gas microsphere liposome composites |
| 05/12/2004 | EP1416970A2 Conjugate |
| 05/12/2004 | EP1416969A2 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| 05/12/2004 | EP1416968A2 Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds |
| 05/12/2004 | EP1416963A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody |
| 05/12/2004 | EP1416945A1 Improved heteropolymer complexes and methods for their use |
| 05/12/2004 | EP1416944A1 Composition for treatment of articular cartilage damage |
| 05/12/2004 | EP1416938A1 Delayed and sustained drug release |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416926A2 Zinc containing compositions for anti-viral use |
| 05/12/2004 | EP1416925A2 Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
| 05/12/2004 | EP1416922A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 05/12/2004 | EP1416918A1 Synergistic filler composition |
| 05/12/2004 | EP1416917A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct) |
| 05/12/2004 | EP1416916A1 Chitin microparticles and their medical uses |
| 05/12/2004 | EP1416914A1 Expandable gastric retention device |
| 05/12/2004 | EP1416907A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 05/12/2004 | EP1383464A4 Nail compositions and methods of administering same |
| 05/12/2004 | EP1309352B1 Antifungal ketoconazole composition for topical use |
| 05/12/2004 | EP1292303B1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 05/12/2004 | EP1154778B1 Pharmaceutical preparation containing dithranol |
| 05/12/2004 | EP1152753B1 Combinations of formoterol and fluticasone propionate for asthma |
| 05/12/2004 | EP1151756A4 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 05/12/2004 | EP1115818B1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 05/12/2004 | EP1102592B1 Coumarin and related aromatic-based polymeric prodrugs |
| 05/12/2004 | EP1069898B1 Topical antiseptic compositions and methods |
| 05/12/2004 | EP1067966B1 Ophthalmic composition comprising a beta-blocker |
| 05/12/2004 | EP1056487B1 Biodegradable shape memory polymers |
| 05/12/2004 | EP1054662B1 Water-soluble eye drop |
| 05/12/2004 | EP1037667B1 Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 05/12/2004 | EP1019027A4 Implantable collagen-containing putty material |
| 05/12/2004 | EP0906015A4 Liver retention clearing agents |
| 05/12/2004 | EP0904113B1 Microencapsulated fluorinated gases for use as imaging agents |
| 05/12/2004 | EP0710261B1 Biodegradable particles |
| 05/12/2004 | EP0627912B1 Gels for encapsulation of biological materials |
| 05/12/2004 | CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease |
| 05/12/2004 | CN1496270A Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 05/12/2004 | CN1496258A Methods of administering epothilone analogs for treatment of cancer |
| 05/12/2004 | CN1496253A 新组合物 The new composition |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1494916A Chinese medicine composition for promoting bllod circulation and its preparation method |
| 05/12/2004 | CN1494911A Slowly-reteased preparation of erythromycin derivative |
| 05/12/2004 | CN1494908A Stable tibolone composition |
| 05/12/2004 | CN1494900A Slow releasing composition and its preparing method |
| 05/12/2004 | CN1494899A Slowly-released dosage form containing asperline |
| 05/12/2004 | CN1494898A Valacycloguanosine tablet containing colloid silica |
| 05/12/2004 | CN1494885A Granulation method of raw medicine component preparation |
| 05/12/2004 | CN1149283C Stable transglutaminase preparations and processer for producing them |
| 05/12/2004 | CN1149207C Method for preparing gama-unsaturated beta-lactone and use thereof as aromatic and flavouring ingredient |
| 05/12/2004 | CN1149102C Stabilized preparations of beta-lactam anitbiotic |
| 05/12/2004 | CN1149083C Pharmaceutical compositions containing irbesartan |
| 05/12/2004 | CN1149078C Treatment of chronic inflammatory disorders of gastrointestinal tract |
| 05/12/2004 | CN1149077C Rapidly disintegrable solid preparation |
| 05/12/2004 | CN1149076C Preparation of powder agglomerates |
| 05/12/2004 | CN1149075C Enteric coated pharmaceutical compsn, and method of mfg. |
| 05/12/2004 | CN1149073C Medicinal aerosol products |
| 05/12/2004 | CN1149072C New pharmaceutical composition with anaesthetic effect |
| 05/12/2004 | CN1149021C Liquid oral compositions comprising a calcium compound and an acidulant |
| 05/11/2004 | US6734188 Composition for treatment of constipation and irritable bowel syndrome |
| 05/11/2004 | US6734170 Cellular uptake of bioactive agents |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734167 Uses of transport proteins |
| 05/11/2004 | US6734162 Mixture of buffer, zinc, phenolic preservative and isotonic agent |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734008 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/11/2004 | US6733790 Heating an aqueous solution of a gel former, an anionic polymer selected from a salt of alginic acid and an anionic chitosan derivative, then adding to an aqueous solution of chitosan; stability in the presence of anionic surfactants |
| 05/11/2004 | US6733788 Temperature controlled solute delivery system |
| 05/11/2004 | US6733782 Core tablet for controlled release of gliclazide after oral administration |
| 05/11/2004 | US6733777 Cationic reagents of transfection |
| 05/11/2004 | US6733769 Edible viscosity lowering polysaccharide; a maltodextrin-glucomannan complex |
| 05/11/2004 | US6733767 Liquid polymeric compositions for controlled release of bioactive substances |
| 05/11/2004 | US6733754 Adjuvants for use in vaccines |
| 05/11/2004 | US6733753 Composition and method for treating inflammatory diseases |
| 05/11/2004 | US6733751 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 05/11/2004 | US6732738 Method to enhance healing of sternum after sternotomy |
| 05/11/2004 | CA2312898C Long acting injectable formulations containing hydrogenated castor oil |
| 05/11/2004 | CA2284482C Treatment of cardiomyopathy |
| 05/11/2004 | CA2272442C Lozenge for the modified releasing of active substances in the gastrointestinal tract |
| 05/11/2004 | CA2225960C Pharmaceutical compositions |
| 05/11/2004 | CA2101779C Defoaming composition |